Drug intelligence / Profile preview

hyperici extractum oleosum

Development stage: Preclinical
Administration: Vaginal, Topical

Overview

Hyperici extractum oleosum is an oily extract of St. John's wort (Hypericum perforatum). It contains active components such as hypericin and hyperforin extracted into an oil base. This extract is used for its anti-inflammatory, antimicrobial, and wound healing properties. It has been studied specifically in vaginal formulations for the treatment of non-specific vaginitis.

Other names: St. John's wort oil extract

Targets

CYP3A4 (Cytochrome P450 3A4)MAT (Monoamine transporters)ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on hyperici extractum oleosum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyperici extractum oleosum.

Explore the full profile